Abstract
A sequence of chronologic steps leading to the identification of exclusively paternal chromosomes in most hydatidiform moles has been developed. It had long been recognized that most moles were chromatin-positive at the nuclear margin. This was confusing, however, since one would ordinarily expect a 50:50 ratio of chromatin-positive to chromatin-negative moles. The initial large study by Baggish and Woodruff (1) on moles treated in Singapore revealed that all 90 moles studied showed well-defined heterochromatin bodies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baggish, M. S., Woodruff, J. D., Tow, S. H., and Jones, N., Sex chromatin pattern in hydatidiform mole, Amer. J. Obstet. Gynecol. 102:362 (1968).
Surti, U. and Szulman, A., Complete hydatidiform mole with 46 XY karyotype, Human Genetics 51:153 (1979).
Lawler, S., HLA and trophoblastic tumours, Brit. Med. Bull. 34: 305 (1978).
Shaw, A. R. E., Dasgupta, M. K., Kovithavongs, T., Johny, K. V., LeRiche, J. C., Dossetor, J. B., and McPhearson, T. A., Humoral and cellular immunity to paternal antigens in trophoblastic neoplasia, Int. J. Cancer 24:586 (1979).
Tomoda, Y., Fuma, M., Saiki, N., Ishivuka, Z., and Akaza, T., Immunologic studies in patients with trophoblastic neoplasia, Amer. J. Obstet. Gynecol. 126:661 (1976).
Robinson, E., Ben-Hur, N., Zuckerman, H., and Neuman, Z., Further immunologic studies in patients with choriocarcinoma and hydatidiform mole, Cancer Res. 27:1202 (1967).
Bagshawe, K., Choriocarcinoma: the clinical biology of the trophoblast and its tumors, London, Arnold (1969), p. 292.
Mogensen, B. and Kissmeyer-Nielson, F., Histocompatibility antigens on the HLA locus in generalized gestational choriocarcinoma, Lancet 1:721 (1968).
Mogensen, B., Kissmeyer-Nielsen, F., and Hauge, M., Histocompatibility antigens on the HLA locus in gestational choriocarcinoma, Transplant. Proc. 1:76 (1969).
Rudolph, R. and Thomas, E., Histocompatibility studies in patients with trophoblastic tumors, Amer. J. Obstet. Gynecol. 108:1126 (1970).
Temin, H. M., The protovirus hypothesis: speculations on the significance of RNA directed DNA synthesis for normal develop-ment and for carcinogenesis, J. Natl. Cancer Inst. 46:111 (1971).
Temin, H. M., Nature of the provirus of Rous sarcoma, Natl. Cancer Inst. Monogr. 17:557 (1964).
Civantos, F. and Rywlin, A. M., Carcinomas with trophoblastic differentiation and secretion of chorionic gonadotrophins, Cancer 29:789 (1972).
Regan, J. F. and Cremin, J. H., Chorioniepthelioma of the stomach, Amer. J. Surg. 100:224 (1967).
Rosen, S. W., Becker, C. E., Schlaff, S., Easton, J., and Gluck, M. C., Ectopic gonadotropin production before clinical recognition of bronchogenic carcinoma, New Engl. J. Med. 279: 640 (1968).
McKechnie, J. C. and Fechner, R., Choriocarcinoma and adenocarcinoma of the esophagus with gonadotropin secretion, Cancer 27:694 (1971).
Castleman, B., Scully, R. E., and McNeely, B. U., Case records of the Massachusetts General Hospital, New Engl. J. Med. 286: 713 (1972).
Ainsworth, R. W. and Gresham, G. A., Primary chorioncarcinoma of the urinary bladder in a male, J. Pathol. Bacteriol. 79: 185 (1960).
Edmonds, L. C. and Cerrera, G. M., Extragenital choriocarcinoma, J. Pediatr. 67:94 (1965).
Bennington, J. L., Haber, S. L., and Schweid, A., Primary mediastinal choriocarcinoma, Dis. Chest 46:623 (1964).
Jernstrom, P. and McLaughlin, H., Choriocarcinoma of the thymus, J. Amer. Med. Assoc. 182:147 (1962).
McArthur, J. W., Para-endocrine phenomena in obstetrics and gynecology, Progr. Gynecol. 4:146 (1963).
Rubin, P., Cancer of the urogenital tract: testicular tumors, J. Amer. Med. Assoc. 213:89 (1970).
Hershman, J. M., Starnes, W. R., Kenimer, J. G., and Pattillo, R. A., Human chorionic thyrotropin, Proc. 4th Intl. Congr. Hormonal Steroids Amsterdam, Excerpta Medica.
Breen, J. L., Ovarian malignancy in children, with special reference to the germ-cell tumors, Ann. N. Y. Acad. Sci. 12: 658 (1967).
Stevens, L. C., Genetic control of experimental teratocarcinogenesis in mice, Anat. Rec. 151:420 (1965).
Billingham, R. E., Transplantation immunity and the maternal-fetal relation, New Engl. J. Med. 270:667 (1964).
Simmons, R. L. and Russell, P. S., The antigenicity of mouse trophoblast, Ann. N. Y. Acad. Sci. 99:717 (1962).
Moller, G., Beckman, V., and Lundgren, G., In vitro destruction of human fibroblasts by non-immune lymphoid cells, Nature 212:1203 (1966).
Kirby, D. R., Bradbury, W. D., and Goldstein, D. J., Antigen barrier in the mouse placenta, Nature 204:548 (1964).
Bradbury, S., Billington, W. D., and Kirby, D. R., A histochemical and electron microscopical study of fibrinoid of the mouse placenta, J. Roy. Microsc. Soc. 84:199 (1965).
Currie, G. A., Doornick, A., and Bagshawe, K. D., Effect of neuraminidase on the immunogenicity of early mouse trophoblast, Nature 219:191 (1968).
Haskova, V., Transplantation non-antigenicity of the fetal placenta, Nature 193:278 (1962).
Douglas, G. W., The immunological role of the placenta, Obstet. Gynecol. Survey 20:442 (1965).
Lanman, J. T., Herod, L., and Fikrig, S., Homograft immunity in pregnancy survival rates in rabbits born of ova transplan-ted into sensitized mothers, J. Exptl. Med. 119:781 (1964).
Tanigaki, N., Nakamuro, K., Natori, T., et al., Common antigenic structures of HLA antigens, Transplantation 18:74 (1974).
Doherty, P., Blanden, R., and Zinkernagel, R., Specificity of virus T cells for H-2K and H-2D compatible interaction: implication diversity, Transplant. Proc. 29:89 (1976).
Bevan, M., The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens, J. Exptl. Med. 142:1349 (1975).
Benacerraf, M. and McDevitt, H., The histocompatibility linked immune response genes, Science 175:273 (1972).
McDevitt, H. and.Bodmer, W., HL-A immune-response genes and disease, Lancet 1:1269 (1974).
Blanden, R., Doherty, P., Dunlop, M., et al., Genes required for cytotoxicity against virus infected target cells in K and D regions of H complex, Nature 254:269 (1975).
Shearer, G., Rehn, T., and Garbarino, C., Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine major histocompatibility complex, J. Exptl. Med. 141:1348 (1975).
Shearer, G., Cell-mediated cytotoxicity to trinitrophenylmodified syngeneic lymphocytes, Eur. J. Immunol. 4:527 (1974).
Jensen, D. and Good, S., Mixed lymphocyte reaction and placentation, Nature New Biol. 240:211 (1972).
Billington, W., Influence of immunological dissimilarity of mother and fetus on size of placenta in mice, Nature 202:317 (1964).
Faulk, W. and Temple, A., Distribution of beta2microglobulin and HLA in chorionic villi in human placentae, Nature 262: 799 (1976).
Johnson, D. and Faulk, W., Immunological studies of human placentae: identification and distribution of proteins in immature chorionic villi, Immunology 34:1027 (1975).
Goodfellow, P., Barnstable, C., Bodmer, W., et al., Expression of HLA antigen systems on placenta, Transplantation 22:595 (1976).
Trowsdale, J., Bodmer, W., Pattillo, R., and Travers, P., Expression of HLA-ABC and beta2microglobulin in human choriocarcinoma cell lines, J. Exptl. Med. 152 (1980).
Loke, Y., Joysey, V., and Borland, R., HL-A antigens on human trophoblast cells, Nature 232:403 (1971).
Wegmann, T., Singh, B., and Carlson, G., Allogeneic placenta is a paternal strain antigen immunoabsorbent, J. Immunol. 122:270 (1979).
Brochier, J., Bonneau, M., Robert, M., et al., Anti-HLA-R alloantibodies eluted from human placental tissue, Transplant. Proc. 9:779 (1979).
Barnstable, C. and Bodmer, W., Immunology and the fetus, Lancet 1:326 (1978).
Gleicher, N., Beers, P., Cohen, C. J., Kerenyi, T., and Gusberg, S. B., Leukocyte migration enhancement as an indicator of immunologic enhancement. I. Pregnancy, Amer. J. Obstet. Gynecol. 136:1 (1980).
Gleicher, N., Beers, P., Cohen, C. J., Kerenyi, T., and Gusberg, S. B., Leukocyte migration enhancement as an indicator of immunologic enhancement. II. Malignancy, Amer. J. Obstet. Gynecol. 136:126 (1980).
Gleicher, N., Deppe, G., and Cohen, C. J., Common aspects of immunologic tolerance in pregnancy and malignancyObstet. Gynecol. 54:335 (1979).
Gerencer, M., Kastelan, A., Drazancic, A., et al., The HLA antigens in women with recurrent abnormal pregnancies of unknown etiology, Tissue Antigens 12:223 (1978).
Billingham, R., Transplantation immunity and the maternal-fetal relation, New Engl. J. Med. 270:667 (1964).
Anderson, J., Transplantation - nature’s success, Lancet 2: 1077 (1971).
Gerencer, M., Drazancic, A., and Kuvacic, I., HLA studies in women with recurrent gestational disorders, Fertil. Steril. 31:401 (1979).
Komlos, L. and Halbrecht, I., Repeated abortions and histocompatibility antigens. Can HLA antigen restricted gene dose effects influence the feto-maternal relationship, Med. Hypotheses 5:901 (1979).
Tomoda, U., Fuma, M., Saiki, N., et al., Immunologic studies in patients with trophoblastic neoplasia, Amer. J. Obstet. Gynecol. 126:661 (1976).
Robinson, E., Ben-Hur, N., Zuckerman, H., et al., Further immunologic studies in patients with choriocarcinoma and hydatidiform mole, Cancer Res. 27:1202 (1967).
Bagshawe, K., Choriocarcinoma: The clinical biology of tropho-blast and its tumors, London: Arnold (1969).
Bach, F., Bach, M., and Klein, J., Genetic and immunological complexity of major histocompatibility regions, Science 176: 1024 (1972).
Pattillo, R. A., HLA haplotypes in choriocarcinoma, in: “Transcripts of 7th Rochester Trophoblast Conference,” H. Thiede, ed., p. 110 (1977).
Hammond, C. and Parker, R. T., Diagnosis and treatment of trophoblastic disease: a report from the Southeastern Regional Center, Obstet. Gynecol. 35:132 (1970).
Curry, S., Hammond, C. B., Tyrey, L., Creasman, W. T., et al., Hydatidiform mole: diagnosis, management and long-term follow up, Obstet. Gynecol. 45:1 (1975).
Doherty, P. C., Blanden, R. V., Zinkernagel, R. M., Specificity of virus-immune effector T-cells for H-2K and H-2D compatible interaction: implications for H-antigen diversity, Transplant. Rev. 29:89 (1976).
Gordon, R. D., Simpson, E., and Samelson, L. C., In vitro cell-mediated immune responses to the male specific (H-Y) antigen in mice, J. Exptl. Med. 142:1108 (1975).
Shearer, G., Cell-mediated cytotoxicity to trinitrophenylmodified syngeneic lymphocytes, Eur. J. Immunol. 4:527 (1974).
Fisher, B. and Fisher, E. T., Studies concerning the regional lymph node in cancer, Cancer 27:1001 (1971).
Khoo, S. K. and Mackay, E. R., Immunologic reactivity of female patients with genital cancer: status in preinvasive, locally invasive, and disseminated disease, Amer. J. Obstet. Gynecol. 119:1018 (1974).
Nalick, R. H., DiSaia, P. J., Rea, T. H., and Morrow, C. P., Immunocompetence and prognosis in patients with gynecologic cancer, Gynecol. Oncol. 2:81 (1974).
Chen, S. S., Koffler, D., and Coheri, C. J., Cellular hypersensitivity in patients with squamous-cell carcinoma of the cervix, Amer. J. Obstet. Gynecol. 121:91 (1975).
Chen, S. Y., Koffler, D., and Cohen, C. J., Cell-mediated immunity in patients with ovarian carcinoma, Amer. J. Obstet. Gynecol. 115:467 (1973).
DiSaia, P. J., Sinkovics, J. G., Rutledge, R. N., and Smith, J. P., Cell-mediated immunity to human malignant cells, Amer. J. Obstet. Gynecol. 114:979 (1972).
Nalick, R. H., DiSaia, P. J., Rea, T. H., and Morrow, M. H., Immunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations, Amer. J. Obstet. Gynecol. 118:398 (1974).
Khoo, S. K. and Mackay, E. V., Relation of yell-mediated immunity in women with genital tract cancer to origin, hisoloty, clinical stage and subsequent behavious of neoplasm, Obstet. Gynaecol. Brit. Commonw. 81:229 (1974).
Feldman, M., Williams, R. C., et al., Cell collaboration between T and B lymphocytes and macrophages in antibody production in vivo, in: “Lymphocytes and Their Interactions: Recent Observations,” New York, RAven Press (1975).
David, J. R., Macrophage migration, Fed. Proc. 27:6 (1968).
McCoy, J. L., Jerome, L. F., Dean, J. H., et al., Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma, J. Natl. Cancer Inst. 53:11 (1974).
Pattillo, R. A., Sasaki, S., Katayama, K. P., Roesler, M., and Mattingly, R. F., Genesis of 46,XY hydatidiform mole, Amer. J. Obstet. Gynecol. 141:104 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Pattillo, R.A. (1984). Genetic Origin, Immunobiology, and Gonadotropin Expression in Trophoblast and Nontrophoblast Neoplasms. In: Pattillo, R.A., Hussa, R.O. (eds) Human Trophoblast Neoplasms. Advances in Experimental Medicine and Biology, vol 176. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4811-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4811-5_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4813-9
Online ISBN: 978-1-4684-4811-5
eBook Packages: Springer Book Archive